Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Kohlberg Signs a Definitive Agreement to Acquire Majority Stake in Worldwide Clinical Trials
Worldwide Clinical Trials, a global, full-service contract research organization and an affiliate company of TJC, L.P. announced today that an affiliate of Kohlberg & Company, LLC, a leading private equity firm with over 35 years of experience partnering with...
CD&R to Raise $23bn for Latest Flagship Fund
Clayton, Dubilier & Rice (DC&R) is close to raising $23 billion for its new flagship buyout fund, overshooting its initial target by $3bn to defy an industry-wide slump in fundraising, the Financial Times reported on Tuesday. CD&R asked its investors if it...
Advent Buys Australian Fashion Brand Zimmermann in $1bn Deal
Private equity firm Advent International has bought a majority stake in Australian fashion brand Zimmermann from the founding family and Italian fund Style Capital, it said. While the financial terms of the deal were not disclosed, two people close to the matter said...